Krystal Biotech Director Sells 700 Shares at $222.2 on 2025-12-04

Krystal Biotech, Inc. (KRYS) announced that Director and President Krishnan Suma has executed a series of stock sales on December 4, 2025. Specifically, Suma sold 700 shares at $222.2/share, 5693 shares at $219.53/share, 10,505 shares at $221.78/share, 2,625 shares at $220.34/share, 2,577 shares at $218.72/share, 1,600 shares at $217.04/share, 10,461 shares at $221.82/share, 344 shares at $215.48/share, 956 shares at $214.28/share, 5,419 shares at $219.68/share, 700 shares at $214.25/share, 3,593 shares at $218.83/share, 2,627 shares at $220.52/share, 600 shares at $215.49/share, 1,400 shares at $216.97/share, and 200 shares at $222.38/share.